Clay B. Siegall - 28 May 2021 Form 3 Insider Report for Nurix Therapeutics, Inc. (NRIX)

Role
Director
Signature
/s/ Christine Ring, as Attorney-in-Fact for Clay B. Siegall
Issuer symbol
NRIX
Transactions as of
28 May 2021
Net transactions value
$0
Form type
3
Filing time
01 Jun 2021, 16:19:41 UTC
Previous filing
07 May 2021
Next filing
04 Jun 2021

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.